Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Equivalence Study of Oral Lubiprostone in Chronic Idiopathic Constipation
jRCT2080223387Phase 3
- Sponsor
- Sucampo
- Start
- Nov 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in functional constipation (FC) comparing Lubiprostone 12 mcg BID regimen with Lubiprostone 24 mcg + placebo BID regimen (2 arms).
02
Drugs
cobiprostone
03
Conditions
functional constipation (FC)
Beyond the preview
Go deeper on jRCT2080223387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223387.